Top 20 Companies in Global Gelatin Polypeptide Plasma Expanders Market Worldwide 2025: Market Research Report (2025–2035)
RELEASE DATE: Apr 2026 Author: Spherical InsightsRequest Free Sample Speak to Analyst
Description
According to a research report published by Spherical Insights & Consulting, the global gelatin polypeptide plasma expanders market Size is projected to grow from USD 2.28 billion in 2025 to USD 3.23 billion by 2035, at a CAGR of 3.5% during the forecast period 2025–2035. The global gelatin polypeptide plasma expanders market is expanding steadily due to increasing demand for emergency medical care, rising surgical procedures, and growing need for effective blood volume replacement solutions in healthcare systems worldwide.
Introduction
The global gelatin polypeptide plasma expanders market consists of medical solutions derived from gelatin-based proteins that are used to restore and maintain blood volume in patients experiencing blood loss, trauma, burns, or undergoing surgical procedures. The plasma expanders provide emergency situations with blood transfusion replacements which help to stabilize circulation while restoring hemodynamic balance. The products provide hospitals and intensive care units and emergency care facilities with solutions that deliver rapid results while maintaining safety and cost efficiency. The market experiences consistent development because surgical procedures have increased while traumatic incidents and accidents have become more frequent and critical care treatments have seen higher demand. The market expansion is supported by healthcare system development in emerging markets and increased spending on healthcare services. The combination of an aging population and a rising number of chronic diseases results in increased hospital admissions. Government regulations and approvals from authorities such as the U.S. FDA and European Medicines Agency ensure product safety and quality which encourages global market adoption.
Navigate Future Markets with Confidence: Insights from Spherical Insights LLP
The insights presented in this blog are derived from comprehensive market research conducted by Spherical Insights LLP, a trusted advisory partner to leading global enterprises. Backed by in-depth data analysis, expert forecasting, and industry-specific intelligence, our reports empower decision-makers to identify strategic growth opportunities in fast-evolving sectors. Clients seeking detailed market segmentation, competitive landscapes, regional outlooks, and future investment trends will find immense value in the full report. By leveraging our research, businesses can make informed decisions, gain a competitive edge, and stay ahead in the transition toward sustainable and profitable solutions.
Unlock exclusive market insights—Download the Brochure now and dive deeper into the future of the global gelatin polypeptide plasma expanders market.
Market Segmentation
Global Gelatin Polypeptide Plasma Expanders Market Size, Share & Industry Analysis, By Type (Succinylated Gelatin, Urea-Linked Gelatin), By Application (Surgery, Trauma Care, Intensive Care), By End-Use (Hospitals, Clinics, Emergency Centers), By Region (North America, Europe, Asia-Pacific, Latin America, Middle East & Africa), Analysis and Forecast 2025–2035
Global gelatin polypeptide plasma expanders market Size & Statistics
- The Market size of global gelatin polypeptide plasma expanders was estimated to be worth USD 2.28 billion in 2025.
- The Market is Going to Expand at a CAGR of 3.5% between 2025 and 2035.
- The Size of global gelatin polypeptide plasma expanders market is anticipated to reach USD 3.23 billion by 2035.
- North America is expected to generate the fastest demand during the forecast period in the global gelatin polypeptide plasma expanders market.
- Asia Pacific is expected to grow the largest during the forecast period in the global gelatin polypeptide plasma expanders market.
Regional growth and demand
North America is expected to generate fastest demand during the forecast period in the global gelatin polypeptide plasma expanders market. The market expansion occurs because leading the market experiences growth because of advanced healthcare infrastructure and the rising number of surgical procedures and the strong presence of major pharmaceutical companies. The market expansion receives support from strict healthcare regulations and the widespread use of cutting-edge medical technologies. The increasing number of chronic disease cases and trauma cases drives the need for effective blood volume replacement solutions.
Asia-Pacific is expected to grow the largest during the forecast period in the global gelatin polypeptide plasma expanders market. The population growth and improved healthcare infrastructure together with the increasing number of surgical procedures will drive growth in China India and Japan. The market experiences growth through government healthcare investments and expanded emergency medical service access.
Ready to lead the Gelatin Polypeptide Plasma Expanders Market?
Discover the regional trends and growth factors shaping the industry. We’re here to assist with expert, personalized data.
Call +1 303 800 4326 or Send us a message for a personalized consultation.
Top 10 Trends in The Global Gelatin Polypeptide Plasma Expanders Market
- Rising Demand for Emergency Medical Care
- Growth in Surgical Procedures
- Increasing Trauma and Accident Cases
- Expansion of Healthcare Infrastructure
- Adoption in Intensive Care Units
- Advancements in Plasma Expander Formulations
- Growing Demand in Developing Countries
- Focus on Patient Safety and Efficiency
- Increasing Healthcare Expenditure
- Technological Innovations in IV Solutions
- Rising Demand for Emergency Medical Care
The global need for emergency medical services has grown because of increasing accidents and natural catastrophes and critical medical emergencies. Emergency situations require gelatin polypeptide plasma expanders because they provide immediate blood volume restoration to treat patients who experience shock or massive blood loss. Emergency medical technicians use these products because they provide rapid results and simple usage throughout ambulance operations and emergency room facilities and trauma treatment centers. The worldwide market for plasma expanders has grown because healthcare systems and governmental organizations develop their emergency response systems which lead to improved patient outcomes.
- Growth in Surgical Procedures
The worldwide growth of surgical operations has created higher demand for gelatin polypeptide plasma expanders. Surgeons use these solutions during operations to maintain blood volume while they stabilize patients who experience major blood loss. The increasing number of elective and intricate surgical procedures requires hospitals to use volume expanders that work effectively. The combination of technological progress in medicine and better healthcare service accessibility has led to increased surgical activity. The present trend causes a considerable increase in the need for plasma expanders used in contemporary healthcare systems.
- Increasing Trauma and Accident Cases
The emergency medical system requires better solutions because more people experience trauma and experience road and workplace accidents. Gelatin polypeptide plasma expanders function as crucial medical tools for treating blood loss and shock prevention during urgent medical situations. The medical professionals use these devices to stabilize their patients who need more medical intervention and surgical procedures. Developing countries experience rising accident rates because of increased urban development and industrial operations. The market for gelatin plasma expanders now experiences worldwide growth because of this trend which requires effective blood volume replacement methods.
- Expansion of Healthcare Infrastructure
The expansion of healthcare infrastructure in developing regions is essential for increasing the demand for gelatin polypeptide plasma expanders. Hospitals clinics and emergency care facilities are being built through government and private organization investments to enhance healthcare access. Advanced medical treatments become more available through the expansion which includes plasma expanders as a medical solution. Enhanced healthcare systems enable improved surgical control and better management of trauma cases and critical care patients. The worldwide need for effective blood volume replacement solutions keeps increasing as healthcare facilities develop better access to advanced technologies.
- Adoption in Intensive Care Units
Intensive care units use gelatin polypeptide plasma expanders to treat critically ill patients who need constant medical supervision. The solutions establish blood circulation mechanisms which help maintain blood pressure levels and protect essential body organs from life-threatening conditions. Plasma expanders face rising demand because more patients enter intensive care units when they suffer from chronic illnesses or infectious diseases or require complex surgical procedures. The combination of technological advancements in critical care and enhanced hospital infrastructure leads to their increased acceptance. The current market trend generates substantial benefits to the expansion of the worldwide market.
Empower your strategic planning:
Stay informed with the latest industry insights and market trends to identify new opportunities and drive growth in global gelatin polypeptide plasma expanders market. To explore more in-depth trends, insights, and forecasts, please refer to our detailed report.
Top 20 Companies Leading the Global Gelatin Polypeptide Plasma Expanders Market
- Fresenius Kabi AG
- Braun Melsungen AG
- CSL Limited
- Baxter International Inc.
- Grifols S.A.
- Octapharma AG
- Kedrion Biopharma
- Pfizer Inc.
- Sanofi S.A.
- Teva Pharmaceutical Industries Ltd.
- Nipro Corporation
- Otsuka Pharmaceutical Co., Ltd.
- JW Pharmaceutical Corporation
- Sichuan Kelun Pharmaceutical Co., Ltd.
- Huaren Pharmaceutical Co., Ltd.
- China Biologic Products Holdings, Inc.
- Intas Pharmaceuticals Ltd.
- Vifor Pharma Group
- Serum Institute of India Pvt. Ltd.
- Hainan Poly Pharm Co., Ltd.
Unlock exclusive market insights—Download the Brochure now and dive deeper into the future of the global gelatin polypeptide plasma expanders market.
- Fresenius Kabi AG
Headquarters: Bad Homburg, Germany
Fresenius Kabi AG operates as a worldwide healthcare organization which develops essential medical products for infusion and transfusion and clinical nutrition needs. The company plays a significant role in the gelatin polypeptide plasma expanders market by offering intravenous solutions used in emergency and critical care. The company's products enable medical professionals to restore blood volume while maintaining patient stability during surgical procedures and emergency medical situations. Fresenius Kabi dedicates its efforts to research and development while maintaining high product standards to extend healthcare services to all regions of the world. The company established a strong presence in international markets because it operates research facilities and manufacturing plants which provide hospitals and healthcare providers with dependable and efficient medical treatment options.
- Braun Melsungen AG
Headquarters: Melsungen, Germany
Baxter International Inc. operates as a top healthcare provider which delivers various medical products that range from intravenous solutions to complete infusion systems and life-saving therapies for critical conditions. The company is actively involved in the gelatin polypeptide plasma expanders market by offering solutions that help maintain blood volume and support patient care during surgeries and emergencies. Baxter operates hospital systems by developing innovative medical solutions which enhance patient safety and worldwide healthcare service delivery. The company provides hospitals and clinics with dependable products which improve treatment results in critical care environments through its extensive global distribution network and state-of-the-art production facilities.
- CSL Limited
Headquarters: Melbourne, Australia
CSL Limited is a global biotechnology company that develops and delivers innovative therapies for serious and life-threatening medical conditions. The company specializes in plasma-derived therapies and plays an important role in the plasma expanders market. CSL focuses on improving patient outcomes through advanced research and high-quality products used in critical care and emergency medicine. Its strong expertise in plasma science and global distribution network supports healthcare providers worldwide. The company continues to invest in research and development to enhance treatment options and meet the growing demand for effective blood volume replacement solutions.
- Baxter International Inc.
Headquarters: Deerfield, Illinois, USA
Baxter International Inc. operates as a top healthcare provider which delivers various medical products that range from intravenous solutions to complete infusion systems and life-saving therapies for critical conditions. The company is actively involved in the gelatin polypeptide plasma expanders market by offering solutions that help maintain blood volume and support patient care during surgeries and emergencies. Baxter operates hospital systems by developing innovative medical solutions which enhance patient safety and worldwide healthcare service delivery. The company provides hospitals and clinics with dependable products which improve treatment results in critical care environments through its extensive global distribution network and state-of-the-art production facilities.
- Grifols S.A.
Headquarters: Barcelona, Spain
Grifols S.A. operates as an international biopharmaceutical business which develops medicines from plasma and produces medical supplies for hospitals. The company plays a key role in the plasma expanders market by providing solutions that support blood volume replacement and critical care treatments. Grifols focuses on innovation and research in plasma science to develop advanced therapies for patients with serious medical conditions. Its products are widely used in hospitals, emergency care, and surgical procedures. Grifols makes a major contribution to worldwide patient care and healthcare improvements because of its extensive global operations and ongoing research and development investments.
Are you ready to discover more about the global gelatin polypeptide plasma expanders market?
The report provides an in-depth analysis of the leading companies operating in the global gelatin polypeptide plasma expanders market. It includes a comparative assessment based on their product portfolios, business overviews, geographical footprint, strategic initiatives, market segment share, and SWOT analysis. Each company is profiled using a standardized format that includes:
Company Profiles
- Fresenius Kabi AG
- Business Overview
- Company Snapshot
- Products Overview
- Company Market Share Analysis
- Company Coverage Portfolio
- Financial Analysis
- Recent Developments
- Merger and Acquisitions
- SWOT analysis
- Braun Melsungen AG
- CSL Limited
- Baxter International Inc.
- Grifols S.A.
- Octapharma AG
- Kedrion Biopharma
- Pfizer Inc.
- Sanofi S.A.
- Others
Unlock exclusive market insights—Download the Brochure now and dive deeper into the future of the global gelatin polypeptide plasma expanders market.
Conclusion
The global gelatin polypeptide plasma expanders market demonstrates constant expansion which results from rising emergency medical service needs and increasing surgical operations and demand for better blood volume replacement methods. The market expansion benefits from three factors, which include improved healthcare infrastructure and higher healthcare spending and the increasing incidence of both traumatic and chronic medical conditions. North America will experience the strongest demand because its advanced healthcare system supports various pharmaceutical companies and people widely use new medical technologies. The Asia-Pacific region will lead market expansion because its population grows and its healthcare centres improve and its government funding for healthcare services rises. The three main companies which dominate the market include Fresenius Kabi AG and B. Braun Melsungen AG and CSL Limited and Baxter International Inc. and Grifols S.A. The market will experience steady growth because healthcare advancements and rising global demand will drive market expansion.
Our Reports:
France Nebulizers Market Size Growth, Report 2035
France Surgical Microscopes Market Size Growth to 2035
Germany Fatty Methyl Ester Sulfonate Market Size Growth to 2035
Germany Antibiotic Resistance Market Size Growth, Forecast to 2035
About the Spherical Insights & Consulting
Spherical Insights & Consulting is a market research and consulting firm which provides actionable market research study, quantitative forecasting and trends analysis provides forward-looking insight especially designed for decision makers and aids ROI. Which is catering to different industry such as financial sectors, industrial sectors, government organizations, universities, non-profits and corporations. The company's mission is to work with businesses to achieve business objectives and maintain strategic improvements.
CONTACT US:
For More Information on Your Target Market, Please Contact Us Below:
Phone: +1 303 800 4326 (the U.S.)
Phone: +91 90289 24100 (APAC)
Email: inquiry@sphericalinsights.com, sales@sphericalinsights.com
Contact Us: https://www.sphericalinsights.com/contact-us
Need help to buy this report?